Electrophysiological changes of cardiac function during antidepressant treatment

Therapeutic Advances in Cardiovascular Disease

Volumn 3, Issue 1, 2009, Pages 29-43

  Sala, Michela ^a   Lazzaretti, Matteo ^a   Vidovich, Giulia ^a   Caverzasi, Edgardo ^a   Barale, Francesco ^a   D’allio, Giorgio ^b   Brambilla, Paolo ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b Department of Mental Health ^*  (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Heart rate; Long QT syndrome; Tachyarrhythmias

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CISAPRIDE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LITHIUM; LOXAPINE; MAPROTILINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PEMOLINE; PHENOTHIAZINE; PLACEBO; REBOXETINE; SERTINDOLE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; VENLAFAXINE;

AUTONOMIC NERVOUS SYSTEM; BOOTSTRAPPING; BRUGADA SYNDROME; CALCIUM CURRENT; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEPRESSION; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG OVERDOSE; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PROTECTION; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LIMBIC SYSTEM; PANIC; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; REVIEW; SIDE EFFECT; SUDDEN DEATH; SURVIVAL RATE; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ANTIDEPRESSIVE AGENTS; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; DEPRESSION; ELECTROCARDIOGRAPHY; HEART DISEASES; HEART RATE; HUMANS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 68749104985     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708096282     Document Type: Review

References (114)

1. Akhtar, M. and Goldschlager, N.F. (2006) Brugada electrocardiographic pattern due to tricyclic antidepressant overdose. J Electrocardiol 39 (3): 336-339.
2. Akselrod, S., Gordon, D., Ubel, F.A., Shannon, D.C., Berger, A.C., Cohen, R.J. et al. (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213 (4504): 220-222.
3. Amitai, Y. and Frischer, H. (2006) Excess fatality from desipramine in children and adolescents. J Am Acad Child Adolesc Psychiatry 45 (1): 54-60.
4. Anson, B.D., Ackerman, M.J., Tester, D.J., Will, M.L., Delisle, B.P., Anderson, C.L. et al. (2004) Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels. Am J Physiol Heart Circ Physiol 286 (6): 2434-2441.
5. Antzelevitch, C. (2004) Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesis. Ann Med 36(Suppl 1): 5-14.
6. Antzelevitch, C. (2005) Cardiac repolarization. The long and short of it. Europace 7(Suppl 2): 3-9.
7. Antzelevitch, C. and Shimizu, W. (2002) Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 17 (1): 43-51.
8. Appleby, M., Mbewu, A. and Clarke, B. (1995) Fluoxetine and ventricular torsade - is there a link?. Int J Cardiol 49 (2): 178-180.
9. Babaliaros, V.C. and Hurst, J.W. (2002) Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine. Clin Cardiol 25 (8): 395-398.
10. Ballenger, J.C., Davidson, J.R., Lecrubier, Y., Nutt, D.J., Jones, R.D. and Berard, R.M. (2001) Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry 62(Suppl 8): 64-67.
11. Bezzina, C.R., Shimizu, W., Yang, P., Koopmann, T.T., Tanck, M.W., Miyamoto, Y. et al. (2006) Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113 (3): 338-344.
12. Bloor, C.M. (2000) Depression: a symptom of coronary artery disease or a pathogenetic factor?. Psychosom Med 62 (5): 606-607.
13. Bolognesi, R., Tsialtas, D., Vasini, P., Conti, M. and Manca, C. (1997) Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. Am J Cardiol 79 (2): 242-245.
14. Brugada, P. and Brugada, J. (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 (6): 1391-1396.
15. Cacioppo, J.T., Berntson, G.G., Binkley, P.F., Quigley, K.S., Uchino, B.N. and Fieldstone, A.G. (1994) Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology 31 (6): 586-598.
16. Carney, R.M. and Freedland, K.E. (2003) Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 54 (3): 241-247.
17. Carney, R.M., Rich, M.W., Freedland, K.E., Saini, J., teVelde, A., Simeone, C. et al. (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50 (6): 627-633.
18. Chan, A., Isbister, G.K., Kirkpatrick, C.M. and Dufful, S.B. (2007) Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 100 (10): 609-615.
19. Chen, S.W. (2007) A new algorithm developed based on a mixture of spectral and nonlinear techniques for the analysis of heart rate variability. J Med Eng Technol 31 (3): 210-219.
20. Cohen, H., Benjamin, J., Geva, A.B., Matar, M.A., Kaplan, Z. and Kotler, M. (2000) Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res 96 (1): 1-13.
21. Crotti, L., Lundquist, A.L., Insolia, R., Pedrazzini, M., Ferrandi, C., de Ferrari, G.M. et al. (2005) KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation 112 (9): 1251-1258.
22. Curione, M., Bernardini, F., Cedrone, L., Proietti, E., Danese, C., Pellegrino, A.M. et al. (1998) The chaotic component of human heart rate variability shows a circadian periodicity as documented by the correlation dimension of the time-qualified sinusal R-R intervals. Clin Ter 149 (6): 409-412.
23. Curran, M.E., Splawski, I., Timothy, K.W., Vincent, G.M., Green, E.D. and Keating, M.T. (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (5): 795-803.
24. Curry, S.C., Kashani, J.S., LoVecchio, F. and Holubek, W. (2005) Intraventricular conduction delay after bupropion overdose. J Emerg Med 29 (3): 299-305.
25. Davidson, J., Watkins, L., Owens, M., Krulewicz, S., Connor, K., Carpenter, D. et al. (2005) Effects of paroxetine and venlafaxine XR on heart rate variability in depression. J Clin Psychopharmacol 25 (5): 480-484.
26. Davidson, K., Jonas, B.S., Dixon, K.E. and Markovitz, J.H. (2000) Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary Artery Risk Development in Young Adults. Arch Intern Med 160 (10): 1495-1500.
27. Delpon, E., Tamargo, J. and Sanchez-Chapula, J. (1991) Further characterization of the effects of imipramine on plateau membrane currents in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 344 (6): 645-652.
28. Dick, I.E., Brochu, R.M., Purohit, Y., Kaczorowski, G.J., Martin, W.J. and Priest, B.T. (2007) Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 8 (4): 315-324.
29. Dubnov, G., Fogelman, R. and Merlob, P. (2005) Prolonged QT interval in an infant of a fluoxetine treated mother. Arch Dis Child 90 (9): 972-973.
30. Finn, J.M., Goettee, J.D., Toroczkai, Z., Anghel, M. and Wood, B.P. (2003) Estimation of entropies and dimensions by nonlinear symbolic time series analysis. Chaos 13 (2): 444-456.
31. Fitzgerald, P.T. and Ackerman, M.J. (2005) Drug-induced torsades de pointes: the evolving role of pharmacogenetics. Heart Rhythm 2(2 Suppl): S30-S37
32. Fossa, A.A., Gorczyca, W., Wisialowski, T., Yasgar, A., Wang, E., Crimin, K. et al. (2007) Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants. J Pharmacol Toxicol Methods 55 (1): 78-85.
33. Fossa, A.A., Wisialowski, T. and Crimin, K. (2006) QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization. J Pharmacol Exp Ther 316 (2): 498-506.
34. Fossa, A.A., Wisialowski, T., Magnano, A., Wolfgang, E., Winslow, R., Gorczyca, W. et al. (2005) Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition. J Pharmacol Exp Ther 312 (1): 1-11.
35. Fraguas Jr, R., Marci, C., Fava, M., Iosifescu, D.V., Bankier, B., Loh, R. et al. (2007) Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment. Psychiatry Res 151(1-2): 169-172.
36. Friberg, L.E., Isbister, G.K. and Duffull, S.B. (2006) Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 61 (2): 177-190.
37. Glassman, A.H. (2002) Clinical management of cardiovascular risks during treatment with psychotropic drugs. J Clin Psychiatry 63(Suppl 9): 12-17.
38. Glassman, A.H., Bigger, J.T., Gaffney, M. and van Zyl, L.T. (2007) Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch Gen Psychiatry 64 (9): 1025-1031.
39. Glassman, A.H., O'Connor, C.M., Califf, R.M., Swedberg, K., Schwartz, P., Bigger Jr, J.T. et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (6): 701-709.
40. Glenny, R.W., Robertson, H.T., Yamashiro, S. and Bassingthwaighte, J.B. (1991) Applications of fractal analysis to physiology. J Appl Physiol 70 (6): 2351-2367.
41. Goldberger, A.L. and West, B.J. (1992) Chaos and order in the human body. MD Comput 9 (1): 25-34.
42. Goldgran-Toledano, D., Sideris, G. and Kevorkian, J.P. (2002) Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 346 (20): 1591-1592.
43. Goodnick, P.J., Jerry, J. and Parra, F. (2002) Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 3 (5): 479-498.
44. Gorman, J.M. and Sloan, R.P. (2000) Heart rate variability in depressive and anxiety disorders. Am Heart J 140(Suppl 4): 77-83.
45. Grippo, A.J., Santos, C.M., Johnson, R.F., Beltz, T.G., Martins, J.B. and Felder, R.B. (2004) Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am J Physiol Heart Circ Physiol 286 (2): H619-H626
46. Grossman, P. (1992) Respiratory and cardiac rhythms as windows to central and autonomic biobehavioral regulation: selection of window frames, keeping the panes clean and viewing the neural topography. Biol Psychol 34(2-3): 131-161.
47. Haines, A.P., Imeson, J.D. and Meade, T.W. (1987) Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 295 (6593): 297-299.
48. Hannerz, H. and Borga, P. (2000) Mortality among persons with a history as psychiatric inpatients with functional psychosis. Soc Psychiatry Psychiatr Epidemiol 35 (8): 380-387.
49. Iasemidis, L.D., Sackellares, J.C., Zaveri, H.P. and Williams, W.J. (1990) Phase space topography and the Lyapunov exponent of electrocorticograms in partial seizures. Brain Topogr 2 (3): 187-201.
50. Isbister, G.K., Friberg, L.E. and Duffull, S.B. (2006) Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 32 (7): 1060-1065.
51. Ishii, K., Kuwahara, M., Tsubone, H. and Sugano, S. (1996) Autonomic nervous function in mice and voles (Microtus arvalis): investigation by power spectral analysis of heart rate variability. Lab Anim 30 (4): 359-364.
52. Jiang, W. and Davidson, J.R. (2005) Antidepressant therapy in patients with ischemic heart disease. Am Heart J 150 (5): 871-881.
53. Jo, S.H., Youm, J.B., Lee, C.O., Earm, Y.E. and Ho, W.K. (2000) Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline. Br J Pharmacol 129 (7): 1474-1480.
54. Kanjanauthai, S., Kanluen, T. and Chareonthaitawee, P. (2007) Citalopram induced torsade de pointes, a rare life threatening side effect. Int J Cardiol. [Epub ahead of print].
55. Kawachi, I., Colditz, G.A., Ascherio, A., Rimm, E.B., Giovannucci, E., Stampfer, M.J. et al. (1994 a) Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89 (5): 1992-1997.
56. Kawachi, I., Sparrow, D., Vokonas, P.S. and Weiss, S.T. (1994) Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 90 (5): 2225-2229.
57. Kawachi, I., Sparrow, D., Vokonas, P.S. and Weiss, S.T. (1995) Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study). Am J Cardiol 75 (14): 882-885.
58. Khaykin, Y., Dorian, P., Baker, B., Shapiro, C., Sandor, P., Mironov, D. et al. (1998) Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can J Psychiatry 43 (2): 183-186.
59. Laske, C., Soekadar, S.R., Laszlo, R. and Plewnia, C. (2007) Brugada syndrome in a patient treated with lithium. Am J Psychiatry 164 (9): 1440-1441.
60. Lasser, K.E., Allen, P.D., Woolhandler, S.J., Himmelstein, D.U., Wolfe, S.M. and Bor, D.H. (2002) Timing of new black box warnings and withdrawals for prescription medications. JAMA 287 (17): 2215-2220.
61. Lederbogen, F., Gernoth, C., Weber, B., Colla, M., Kniest, A., Heuser, I. et al. (2001) Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. J Clin Psychopharmacol 21 (2): 238-239.
62. Letsas, K., Korantzopoulos, P., Pappas, L., Evangelou, D., Efremidis, M. and Kardaras, F. (2006) QT interval prolongation associated with venlafaxine administration. Int J Cardiol 109 (1): 116-117.
63. Liljeqvist, J.A. and Edvardsson, N. (1989) Torsade de pointes tachycardias induced by overdosage of zimeldine. J Cardiovasc Pharmacol 14 (4): 666-670.
64. Mann, R.D. (1998) Prescription-event monitoring - recent progress and future horizons. Br J Clin Pharmacol 46 (3): 195-201.
65. Mantel-Teeuwisse, A.K., Klungel, O.H., Verschuren, W.M. and Porsius, A. (2001) Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 54 (11): 1181-1186.
66. Milnes, J.T., Crociani, O., Arcangeli, A., Hancox, J.C. and Witchel, H.J. (2003) Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S 6 mutations at F 656 or Y652. Br J Pharmacol 139 (5): 887-898.
67. Mittleman, M.A., Maclure, M., Sherwood, J.B., Mulry, R.P., Tofler, G.H., Jacobs, S.C. et al. (1995) Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation 92 (7): 1720-1725.
68. Mrowka, R., Unbehaun, A., Schubert, E. and Patzak, A. (1996) [Nonlinear dynamics in regulation of heart rate in healthy infants]. Wien Med Wochenschr 146(13-14): 313-316.
69. Napolitano, C., Rivolta, I. and Priori, S.G. (2003) Cardiac sodium channel diseases. Clin Chem Lab Med 41 (4): 439-444.
70. Pagani, M., Lombardi, F., Guzzetti, S., Rimoldi, O., Furlan, R., Pizzinelli, P. et al. (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59 (2): 178-193.
71. Pentilla, J., Syvalahti, E., Hinkka, S., Kuusela, T. and Scheinin, H. (2001) The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers. Psychopharmacology (Berl) 154 (4): 343-349.
72. Pohl, R., Balon, R., Jayaraman, A., Doll, R.G. and Yeragani, V. (2003) Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans. J Psychosom Res 55 (3): 247-251.
73. Politi, P., Piccinelli, M., Klersy, C., Madini, S., Segagni, L.G., Fratti, C. et al. (2002) Mortality in psychiatric patients 5 to 21 years after hospital admission in Italy. Psychol Med 32 (2): 227-237.
74. Pomerantz, K.B., Fleisher, L.N., Tall, A.R. and Cannon, P.J. (1985) Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I 2 synthesis. J Lipid Res 26 (10): 1269-1276.
75. Priori, S.G. and Cerrone, M. (2005) Genetic arrhythmias. Ital Heart J 6 (3): 241-248.
76. Rasmussen, S.L., Overo, K.F. and Tanghoj, P. (1999) Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol 19 (5): 407-415.
77. Ravina, T., Suarez, M.L. and Mendez-Castrillon, J. (1998) Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope. Int J Cardiol 65 (3): 311-313.
78. Rechlin, T. (1994) The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol 14 (6): 392-395.
79. Rechlin, T., Weis, M. and Claus, D. (1994) Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 27 (3): 124-128.
80. Redfern, W.S., Carlsson, L., Davis, A.S., Lynch, W.G., MacKenzie, I., Palethorpe, S. et al. (2003) Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58 (1): 32-45.
81. Roose, S.P., Glassman, A.H., Attia, E., Woodring, S., Giardina, E.G. and Bigger Jr, J.T. (1998 a) Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 155 (5): 660-665.
82. Roose, S.P., Laghrissi-Thode, F., Kennedy, J.S., Nelson, J.C., Bigger Jr, J.T., Pollock, B.G. et al. (1998 b) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279 (4): 287-291.
83. Rouleau, F., Asfar, P., Boulet, S., Dube, L., Dupuis, J.M., Alquier, P. et al. (2001) Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome. J Cardiovasc Electrophysiol 12 (1): 61-65.
84. Roy, M., Dumaine, R. and Brown, A.M. (1996) HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94 (4): 817-823.
85. Ruschena, D., Mullen, P.E., Burgess, P., Cordner, S.M., Barry-Walsh, J., Drummer, O.H. et al. (1998) Sudden death in psychiatric patients. Br J Psychiatry 172: 331-336.
86. Saenen, J.B., Paulussen, A.D., Jongbloed, R.J., Marcelis, C.L., Gilissen, R.A., Aerssens, J. et al. (2007) A single hERG mutation underlying a spectrum of acquired and congenital long QT syndrome phenotypes. J Mol Cell Cardiol 43 (1): 63-72.
87. Sala, M., Coppa, F., Cappucciati, C., Brambilla, P., d'Allio, G., Caverzasi, E. et al. (2006) Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr Opin Investig Drugs 7 (3): 256-263.
88. Shimizu, W. and Antzelevitch, C. (1999) Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome. J Electrocardiol 32(Suppl): 177-184.
89. Siepmann, M., Grossmann, J., Muck-Weymann, M. and Kirch, W. (2003) Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) 168 (3): 293-298.
90. Sloan, R.P., Shapiro, P.A., Bagiella, E., Myers, M.M., Bigger Jr, J.T., Steinman, R.C. et al. (1994) Brief interval heart period variability by different methods of analysis correlates highly with 24 h analyses in normals. Biol Psychol 38(2-3): 133-142.
91. Steptoe, A., Kunz-Ebrecht, S.R. and Owen, N. (2003) Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 33 (4): 667-674.
92. Straneva-Meuse, P.A., Light, K.C., Allen, M.T., Golding, M. and Girdler, S.S. (2004) Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients. J Affect Disord 79(1-3): 51-61.
93. Strohmer, B. and Schernthaner, C. (2007) Brugada syndrome unmasked by lithium therapy. Wien Klin Wochenschr 119(9-10): 282.
94. Sugihara, G., Grenfell, B. and May, R.M. (1990) Distinguishing error from chaos in ecological time series. Phil Trans R Soc Lond B Biol Sci 330 (1257): 235-251.
95. Sullivan, G.M., Kent, J.M., Kleber, M., Martinez, J.M., Yeragani, V.K. and Gorman, J.M. (2004) Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment. Psychiatry Res 125 (1): 29-39.
96. Tada, H., Sticherling, C., Oral, H. and Morady, F. (2001) Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 12 (2): 275.
97. Tarabar, A.F., Hoffman, R.S. and Nelson, L. (2008) Citalopram overdose: late presentation of torsades de pointes (tdp) with cardiac arrest. J Med Toxicol 4 (2): 101-105.
98. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17 (3): 354-381.
99. Teschemacher, A.G., Seward, E.P., Hancox, J.C. and Witchel, H.J. (1999) Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol 128 (2): 479-485.
100. Traboulsie, A., Chemin, J., Kupfer, E., Nargeot, J. and Lory, P. (2006) T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol Pharmacol 69 (6): 1963-1968.
101. Tulen, J.H., Bruijn, J.A., de Man, K.J., Pepplinkhuizen, L., van den Meiracker, A.H. and Man in ‘t Veld, A.J. (1996) Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 16 (2): 135-145.
102. Turner, A.W. and Malik, M. (1995) Risk stratification and prediction of sudden death following myocardial infarction. Herz 20 (3): 200-212.
103. Varriale, P. (2001) Fluoxetine (Prozac) as a cause of QT prolongation. Arch Intern Med 161 (4): 612.
104. Vieweg, W.V. (2002) Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs. J Clin Psychiatry 63(Suppl 9): 18-24.
105. Vieweg, W.V. and Wood, M.A. (2004) Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics 45 (5): 371-377.
106. Wilens, T.E., Biederman, J., Baldessarini, R.J., Geller, B., Schleifer, D., Spencer, T.J. et al. (1996) Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35 (11): 1491-1501.
107. Wilting, I., Smals, O.M., Holwerda, N.J., Meyboom, R.H., de Bruin, M.L., Egberts, T. C et al. (2006) QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine. Am J Psychiatry 163 (2): 325.
108. Witchel, H.J., Hancox, J.C. and Nutt, D.J. (2003) Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol 23 (1): 58-77.
109. Yeragani, V.K., Balon, R., Pohl, R., Ramesh, C., Glitz, D., Weinberg, P. et al. (1990) Decreased R-R variance in panic disorder patients. Acta Psychiatr Scand 81 (6): 554-559.
110. Yeragani, V.K., Pohl, R., Berger, R., Balon, R., Ramesh, C., Glitz, D. et al. (1993) Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 46 (1): 89-103.
111. Yeragani, V.K. and Rao, K.A. (2003 a) Nonlinear measures of QT interval series: novel indices of cardiac repolarization lability: MEDqthr and LLEqthr. Psychiatry Res 117 (2): 177-190.
112. Yeragani, V.K. and Rao, R. (2003 b) Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder. J Psychosom Res 55 (6): 507-513.
113. Yeragani, V.K., Roose, S., Mallavarapu, M., Radhakrishna, R.K., Pesce, V. et al. (2002) Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiology 46 (3): 125-135.
114. Zahradnik, I., Minarovic, I. and Zahradnikova, A. (2008) Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. J Pharmacol Exp Ther 324 (3): 977-984.